XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Revenues
9 Months Ended
Sep. 30, 2023
Revenues  
Revenues

(6)  Revenues  

We recognize revenue when performance obligations under the terms of a contract with our customer are satisfied. This occurs with the transfer of control of our products to customers when products are shipped. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Sales and other taxes we may collect concurrent with revenue-producing activities are excluded from revenue.

 

A summary of revenue by geographic area, based on shipping destination, for the three and nine months ended September 30, 2023 and 2022 is as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

United States

 

$26,146

 

 

$27,779

 

 

$78,594

 

 

$84,121

 

European Union

 

 

6,695

 

 

 

6,371

 

 

 

21,361

 

 

 

23,851

 

All other regions

 

 

9,070

 

 

 

10,481

 

 

 

25,787

 

 

 

32,679

 

Total

 

$41,911

 

 

$44,631

 

 

$125,742

 

 

$140,651

 

A summary of revenue by product line for the three and nine months ended September 30, 2023 and 2022 is as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Fluid Delivery

 

$17,717

 

 

$19,303

 

 

$52,591

 

 

$64,973

 

Cardiovascular

 

 

17,170

 

 

 

16,780

 

 

 

51,568

 

 

 

50,165

 

Ophthalmology

 

 

2,700

 

 

 

1,607

 

 

 

6,849

 

 

 

4,495

 

Other

 

 

4,324

 

 

 

6,941

 

 

 

14,734

 

 

 

21,018

 

Total

 

$41,911

 

 

$44,631

 

 

$125,742

 

 

$140,651

 

 

More than 98 percent of our total revenue in the periods presented herein is pursuant to shipments initiated by a purchase order (our “contract”) and recognized at a single point in time when the performance obligation of the product being shipped is satisfied, rather than recognized over time, and is presented as a receivable on the balance sheet. Payment is typically due within 30 days.

 

We maintain an allowance for doubtful accounts to reflect estimated losses resulting from the failure of customers to make required payments. We calculate our credit loss allowance for our trade receivables following a lifetime “expected credit loss” measurement objective. An account is written off when we determine the receivable will not be collected. Historically, bad debt has been immaterial.

 

We have elected to recognize the cost of shipping as an expense in cost of sales when control over the product has transferred to the customer.

 

We do not make any material accruals for product returns and warranty obligations because our returns and warranty obligations have been very low due to our focus on quality control.

 

We do not disclose the value of unsatisfied performance obligations for contracts for which we recognize revenue at the amount for which we have the right to invoice. We believe that the complexity added to our disclosures by the inclusion of a large amount of insignificant detail in attempting to disclose information about immaterial contracts would potentially obscure more useful and important information.